TIMOTHY KAMINSKI: Open Payments
NPI 1912324252 · TOLEDO, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$551 in 28 payments from 10 companies in 2025. Trend: 2023 $382 · 2024 $525 · 2025 $551
Food & beverage: $551
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 10 | $161 |
| Indivior Inc. | 3 | $85 |
| E.R. Squibb & Sons, L.L.C. | 4 | $66 |
| Vanda Pharmaceuticals Inc. | 3 | $52 |
| Janssen Pharmaceuticals, Inc | 2 | $39 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $38 |
| ABBVIE INC. | 1 | $31 |
| Axsome Therapeutics, Inc. | 1 | $27 |
| Alkermes, Inc. | 1 | $26 |
| Neurocrine BioSciences, Inc. | 1 | $26 |
Products named: REXULTI, SUBLOCADE, COBENFY, FANAPT, ABILIFY MAINTENA, INVEGA SUSTENNA, CAPLYTA, VRAYLAR.
Industry payments across OH — which companies pay providers there.
